British drugmaker GlaxoSmithKline PLC says it dismissed one employee and a second has resigned in the wake of a scandal over misrepresented data in a research paper published in 2010.
The company says its investigation of recent allegations of questionable data has established that some information in the paper had been misrepresented.
The paper, written by scientists at GlaxoSmithKline’s research centre in China, was published in the prestigious journal Nature Medicine. It covered early, laboratory stage research involving multiple sclerosis.
GlaxoSmithKline says besides the two employees, three others are on administrative leave, pending a final review.
The world’s sixth-biggest drugmaker also has told the journal that the paper should be retracted and that it’s getting all of the authors to sign a statement to that effect.